Viewing Study NCT00349934


Ignite Creation Date: 2025-12-25 @ 2:20 AM
Ignite Modification Date: 2025-12-27 @ 9:34 AM
Study NCT ID: NCT00349934
Status: COMPLETED
Last Update Posted: 2010-01-07
First Post: 2006-07-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma
Sponsor: Immutep S.A.S.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module